Compounded Semaglutide vs Ozempic: FDA Facts Patients Ask
Written by the Innovative Men's Health Editorial Team
Medically reviewed by Alessa Lopez-Castor, ARNP, DNP
Last medically reviewed: September 18, 2026
Searches for compounded semaglutide versus Ozempic—and compounded tirzepatide versus FDA-approved products—often mix together brand names, pharmacy compounding, online sellers, and the temporary policies used during national shortages. Those are not the same things.
The most important distinction is simple: FDA-approved medicines undergo FDA review for safety, effectiveness, manufacturing quality, and labeling before marketing. Compounded drugs are not FDA-approved and do not go through that same premarket review. A compounded medicine may still have a legitimate, patient-specific role in limited circumstances, but it should not be described as identical to an approved product.
This guide is educational. It does not recommend a particular brand, compounded product, pharmacy, dose, or titration schedule.
FDA-Approved GLP-1 Medicines vs Compounded Products
FDA-approved semaglutide products include Ozempic, Wegovy, and Rybelsus, each with its own approved indications and labeling. FDA-approved tirzepatide products include Mounjaro and Zepbound, also with product-specific indications and labeling.
A compounded product is prepared for an individual patient under federal and state compounding rules. FDA states that compounded drugs should generally be used only when a patient’s medical needs cannot be met by an FDA-approved drug or when the approved drug is not commercially available.
“Compounded” does not automatically mean counterfeit—but it also does not mean FDA-approved, FDA-tested, or interchangeable with a branded product. The prescriber, pharmacy, ingredients, labeling, storage, and patient-specific clinical reason all matter.
Why Semaglutide Salt Forms Matter
FDA has specifically warned about semaglutide sodium and semaglutide acetate. These salt forms are different active ingredients from the base form of semaglutide used in FDA-approved medicines.
FDA says it does not have information showing that these salts have the same chemical and pharmacologic properties as the active ingredient in approved drugs, and the agency is not aware of a lawful basis for using the salt forms in compounding. A vial labeled only as “semaglutide” should not be assumed to be equivalent to Ozempic or Wegovy.
The Shortage-Era Rules Changed
During national shortages, federal law provided certain pathways for pharmacies and outsourcing facilities to compound products that might otherwise be restricted as copies of commercially available medicines. FDA later determined that the tirzepatide and semaglutide injection shortages were resolved and wound down the shortage-based enforcement discretion it had announced.
That does not mean every compounded prescription is automatically unlawful, and this article is not legal advice. It means the broad shortage-era market for routine copies is not the same as it was. Legitimate compounding remains tied to applicable law and an individual patient’s medical needs—not simply a preference for a cheaper version of an approved medicine.
Online and Telehealth Red Flags
FDA’s current consumer guidance identifies warning signs that should make patients pause before buying a GLP-1 product online or through a telehealth company.
Claims of equivalence: The seller says a compounded drug is “the same as” an FDA-approved product.
Little or no clinical screening: No licensed clinician evaluates the patient or remains available for follow-up questions.
Prices that seem too good to be true: Deep discounts are paired with vague sourcing or unclear pharmacy information.
Questionable packaging: The shipment arrives damaged, lacks instructions, or lists a pharmacy that cannot be verified.
Research-only language: Products labeled “for research purposes” or “not for human consumption” are sold with instructions for human use.
Improper shipping temperature: An injectable product that requires refrigeration arrives warm or without adequate cooling.
FDA recommends obtaining a prescription from a licensed clinician and filling it through a state-licensed pharmacy. Patients should not use injectable GLP-1 products sold as research chemicals or products that arrive with questionable identity, storage, or labeling.
Why Multi-Dose Vials and Measurement Can Add Risk
FDA has received reports of dosing errors involving compounded injectable semaglutide, including adverse events and hospitalizations. Reported problems have involved patients drawing the wrong amount from multi-dose vials and clinicians miscalculating conversions between milligrams, milliliters, and syringe “units.”
Compounded products can be supplied in different concentrations, container types, and syringe sizes. FDA-approved injectable semaglutide products use standardized presentations and labeling. This article intentionally provides no dose amounts, syringe conversions, or titration instructions.
FDA’s current guidance also highlights contamination concerns with multi-dose sterile vials after repeated entry. Patients should follow the product-specific instructions from the dispensing pharmacy and contact the prescriber or pharmacist whenever labeling, storage, or administration directions are unclear.
Quality, Identity, and Fraudulent Labels
FDA has identified fraudulent products labeled as compounded semaglutide or tirzepatide. In some cases, the pharmacy named on the label did not exist or did not make the product. FDA also warns that illegal online products may contain the wrong ingredient, too much or too little active ingredient, no active ingredient, or harmful substances.
Compounded medicines are not reviewed by FDA before marketing for identity, purity, potency, sterility, effectiveness, or storage integrity in the same way as approved products. That makes source verification and licensed clinical oversight essential.
Questions to Ask Before Accepting Any GLP-1 Prescription
Is this product FDA-approved or compounded?
What is the exact product name and active ingredient?
What licensed pharmacy will dispense it?
Why is a compounded product medically necessary for me?
Who will monitor side effects and answer questions after treatment begins?
How should the product be stored, and what should I do if it arrives warm or damaged?
What should I do if the instructions or label are unclear?
Those questions do not replace a clinical evaluation, but they can expose vague sourcing, misleading equivalence claims, and missing follow-up care.
Care at IMHS in Bellevue and Across Washington
At Innovative Men's Health, questions about compounded and FDA-approved options are addressed as part of a thoughtful medical weight loss evaluation. The starting point is health history, goals, contraindications, current medicines, and shared decision-making—not an automatic prescription.
Browse our services, contact the clinic, or learn about Washington telehealth for eligible adults when clinically suitable. Innovative Men's Health is located at 1940 116th Ave NE Unit 201, Bellevue, WA 98004. Phone: (425) 455-1700.
Key Takeaways
FDA-approved GLP-1 medicines undergo FDA review for safety, effectiveness, quality, and labeling; compounded drugs do not.
Compounded products should not be marketed as identical to an FDA-approved brand.
Semaglutide sodium and semaglutide acetate are different active ingredients from the semaglutide base used in approved products.
The shortage-era compounding landscape changed after FDA determined the semaglutide and tirzepatide injection shortages were resolved.
FDA has warned about fraudulent labels, research-only products, improper shipping temperatures, and dosing errors involving compounded injectables.
Use a licensed clinician and state-licensed pharmacy. Evaluation is required, results vary, and an inquiry does not guarantee a prescription.
Frequently Asked Questions
Is compounded semaglutide the same as Ozempic?
No. Ozempic is an FDA-approved semaglutide product with specific manufacturing, labeling, and approved uses. Compounded semaglutide is not FDA-approved and should not be represented as identical to Ozempic.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
No. Mounjaro and Zepbound are FDA-approved tirzepatide products with product-specific labels. Compounded tirzepatide does not undergo the same FDA premarket review.
Are all compounded GLP-1 prescriptions illegitimate?
No. Compounding can have a lawful, patient-specific role when applicable requirements are met and a patient’s needs cannot be met by an available FDA-approved product. Suitability is a clinical and legal determination for licensed professionals.
What should I do if an injectable GLP-1 product arrives warm or damaged?
Do not assume it is safe to use. Contact the dispensing pharmacy and prescriber immediately for product-specific instructions. FDA warns that inadequate refrigeration can affect quality.
Will a consultation guarantee a prescription?
No. A consultation is an evaluation and shared decision-making process. An inquiry does not guarantee any medicine or outcome.
Keep Reading
Sources
Medical Disclaimer
This article is for general educational purposes only and is not medical advice, diagnosis, treatment, or legal advice. Reading it does not create a provider-patient relationship. Innovative Men's Health does not diagnose readers from this page and does not guarantee weight loss, blood-sugar improvement, medication access, or any other result. This article does not promote compounded semaglutide, compounded tirzepatide, or research products and provides no dosing, titration, syringe-conversion, or brand-shopping instructions. Compounding rules and FDA policies can change. Consult a licensed clinician and pharmacist about your individual situation. Evaluation is required; results vary; and an inquiry does not equal a prescription. Call 911 for a medical emergency.
Comments